» Articles » PMID: 16235676

Predictors of Diabetes Insipidus After Transsphenoidal Surgery: a Review of 881 Patients

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2005 Oct 21
PMID 16235676
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Object: Diabetes insipidus (DI) is a common complication of transsphenoidal surgery. The purpose of this study was to elucidate patient- and surgery-specific risk factors for DI.

Methods: The perioperative records of 881 patients who had undergone transsphenoidal microsurgery at the authors' institution between January 1995 and June 2001 were reviewed. Among 857 patients without preoperative DI, the overall incidence of immediate postoperative DI was 18.3%, with 12.4% of patients requiring treatment with desmopressin at some point during their hospitalization. Persistent DI requiring long-term treatment with desmopressin was noted in 2% of all patients. An observable intraoperative cerebrospinal fluid (CSF) leak was strongly associated with an increased incidence of both transient (33.3%) and persistent (4.4%) DI. Craniopharyngioma and Rathke cleft cyst (RCC) were also associated with an increased incidence of transient and persistent DI, whereas repeated operation was not. Among patients with pituitary adenomas, those with Cushing's disease had an increased risk of transient (22.2%), but not persistent, DI. Patients with a microadenoma were more likely to suffer transient DI than those harboring a macroadenoma (21.6 compared with 14.3%) but were not more likely to experience persistent DI.

Conclusions: Diabetes insipidus remains a common complication of transsphenoidal surgery; however, it is most frequently transient in nature. Patients with an intraoperative CSF leak, a microadenoma, a craniopharyngioma, or an RCC appear to have an increased risk of transient DI. Risk factors for persistent DI include an intraoperative CSF leak, a craniopharyngioma, or an RCC.

Citing Articles

Risk Factors for Development of Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone Secretion after Transsphenoidal Resection of Pituitary Adenoma.

Petito G, Hu A, Zhang G, Min S, Tripathi S, Kumar A J Neurol Surg B Skull Base. 2025; 86(1):39-45.

PMID: 39881750 PMC: 11774605. DOI: 10.1055/a-2235-7419.


Urinary oxytocin secretion after pituitary surgery, early arginine vasopressin deficiency and syndrome of inappropriate antidiuresis.

Constanthin P, Isidor N, de Seigneux S, Momjian S Endocrine. 2024; .

PMID: 39681826 DOI: 10.1007/s12020-024-04131-5.


Prevalence and Clinical Course of Water and Electrolyte Disturbances Following Transsphenoidal Pituitary Adenoma Surgery in Immediate and Early Postoperative Period: A Prospective Observational Study.

Bhardwaj S, Jaiswal A, Yadav S, Gupta D, Yadav R, Singh A Indian J Endocrinol Metab. 2024; 28(4):370-377.

PMID: 39371656 PMC: 11451951. DOI: 10.4103/ijem.ijem_79_24.


Predictive modeling of arginine vasopressin deficiency after transsphenoidal pituitary adenoma resection by using multiple machine learning algorithms.

Chen Y, Zhong J, Li H, Lin K, Wei L, Wang S Sci Rep. 2024; 14(1):22210.

PMID: 39333611 PMC: 11436865. DOI: 10.1038/s41598-024-72486-w.


Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience.

Varaldo E, Sibilla M, Prencipe N, Berton A, Cuboni D, Aversa L Pituitary. 2024; 27(5):714-722.

PMID: 39266909 PMC: 11513737. DOI: 10.1007/s11102-024-01454-4.